Momelotinib (CYT387) Multi-Kinase Inhibition in Hematologic Malignancies and Solid Tumors

Epacadostat (INCB024360) INCB024360 IDO/TDO inhibitor Reverses Lymphocyte Exclusion in Carcinoma Models

Alectinib (CH5424802) Exposure Correlates with Sinus Bradycardia and Cardiotoxicity in ALK-Rearranged NSCLC

LCL161 Sensitizes Non-Small Cell Lung Cancer to Paclitaxel via cIAP Degradation

Rabusertib (LY2603618) and LY2603618 from Selleck Target Chk1 in DNA Damage Response Pathways

A-922500 (DGAT-1 Inhibitor 4a) Directs Neutrophil Lipid Remodeling and Inflammatory Mediator Suppression

TTNPB (Arotinoid acid) Drives RARα and RARγ Signaling to Counteract High-Risk Alzheimer's Disease Phenotypes

4-PBA (4-Phenylbutyric acid) Mitigates Beta-Cell Injury and Systemic Inflammation in Acute Pancreatitis

ARN-509 (Apalutamide) Inhibits Androgen Receptor Signaling in Metastatic Hormone-Sensitive Prostate Cancer

TLR2-IN-C29 TLR2INC29 Inhibits Toll-like Receptor 2 Signaling and Inflammatory Cascades

O-Propargyl-Puromycin Tagging of Nascent Polypeptides in Ribosomal Translatome Profiling Analysis

MG132 SSS attenuates renal fibrosis by stabilizing SnoN and repressing TGF-beta signaling

SC79 Reverses KRT8-Mediated Inhibition of AKT NF-kB Signaling in Lung Cancer

UNC0379 targeting SETD8 restores p53 transcriptional activity to induce apoptosis in neuroblastoma

Geldanamycin (NSC 122750) Geldanamycin inhibitor analogs suppress Hsp90 ATPase and drive cell death

Ceritinib (LDK378) ALK inhibitor Efficacy and CNS Penetration in Advanced NSCLC

BTP2 Calcium Channel inhibitor YM-58483 (BTP2) Attenuates Morphine Tolerance via Astrocytic SOCC Suppression

Z-IETD-FMK from Selleck Suppresses Caspase-8 Mediated Retinal Neuroinflammation in Ischemic Glaucoma Models

STI571 Imatinib Mesylate Suppresses PDGFRα and AKT/mTOR Signaling in Osteosarcoma

Akti-1/2 from Selleck Inhibits Spatial AKT Signaling in Tumors

BLU-667 (Pralsetinib) Targets RET Kinase Active Site to Bypass Gatekeeper Resistance Mutations

Golgicide A Induces LCSC Pyroptosis via GOLPH3/MYO18A Complex Activation

Lonidamine (AF 1890) AF 1890 inhibitor targeting mitochondrial complexes

MIK665 (S64315) S64315 Bcl-2 inhibitor engagement overcomes MCL-1 mediated resistance in AML

L-Kynurenine LKynurenine Mediates Direct Radical Scavenging and Glutathione Defense Activation

PACAP 1-38 PACAP 138 target engagement attenuates ischemia-reperfusion flap damage

10-Deacetylbaccatin-III Conversion via DBAT in Microbial Paclitaxel Biosynthesis

Hesperadin Attenuates Intracerebral Hemorrhage Injury via MST4 Kinase Inhibition and AKT Activation

Bromopyruvic acid (3-BP) Suppresses Glycolytic and Mitochondrial Energy Pathways

DT2216 Targeted Bcl-xL Degradation via VHL Chemically Spares Platelets in T-Cell Lymphoma

PHA-665752 c-Met inhibitor Attenuates HGF-Driven Protections in Sepsis-Induced Endothelial Pyroptosis

Z-VAD(OH)-FMK from Selleck Inhibits Pan-Caspase Proteolysis and Modulates Programmed Cell Death Pathways

Bavdegalutamide (ARV-110) Bavdegalutamide inhibitor AR Degradation Pharmacokinetics

Chloroquine diphosphate in Immunohematology: Dissociation Analysis of Cold-Reactive IgM

A-769662 Target Engagement of AMPK Suppresses NF-kB and MAPK Inflammatory Signaling

TIC10 (ONC201) Targeting DRD2 and ClpP to Induce ISR-Mediated Apoptosis

SQ22536 Inhibition of Adenylyl Cyclase in Platelet Signaling Pathways

ICI 118551 Hydrochloride from Selleck for Selective Beta-2 Adrenergic Receptor Blockade

GDC-0068 Akt inhibitor Evaluation in PIK3CA/AKT1/PTEN-Altered HR+/HER2- Advanced Breast Cancer

Harringtonine from Selleck Inhibits Ribosomal Translation in Combination Chemotherapy for Relapsed Leukemia

Novobiocin Sodium (Cathomycin, Albamycin) Antineoplastic and I inhibitor Target DNA Gyrase in Bovine Mastitis

A-1331852 inhibitor target engagement in BCL-XL pathway and MLL-fusion AML therapeutic dynamics

CH5424802 from Selleck (Alectinib) Potently Inhibits ALK in Crizotinib-Resistant Lung Cancer

Monomethyl auristatin E (MMAE) Conjugate Efficacy in Advanced Gastric Cancer

KU-60019 KU60019 ATM Kinase Inhibition in KMT2A-Rearranged Leukemia

Capmatinib (INC280) Inhibits MET Receptor Tyrosine Kinase in Advanced Dysregulated NSCLC

Nilotinib (AMN-107) Inhibition of Abl Kinase Promotes Autophagic Synuclein Clearance

VE-821 from Selleck Suppresses ATR Kinase to Enhance Carbon Ion Radiosensitivity

AZD1390: ATM Kinase Inhibition and Radiosensitization in Breast Cancer Brain Metastases

Acalabrutinib (ACP-196) and ACP196 Covalently Inhibit BTK in Relapsed High-Risk CLL

Barasertib-HQPA (AZD2811) from Selleck Targets Aurora B Kinase via ATP-Competitive Inhibition in AML

Bay K 8644 from Selleck Modulates L-Type Calcium Currents in Cardiomyocytes

Clozapine N-oxide (CNO chemical) from Selleck Directs NLRP3 Inflammasome and Cytokine Modulation

Q-VD-Oph Caspase inhibitor Suppresses Apoptosis and Mediates Multi-Organ Tissue Protection

AZD6738 Ceralasertib Sensitizes Radioimmunotherapy via ATR Inhibition and cGAS/STING Activation

Cyclosporin A Antineoplastic and I inhibitor Principles in Social-Ecological CSA Disclosure Models

SC79 from Selleck Mediates Akt Activation for Anti-Apoptotic Neuroprotection in Ischemia

AZD5363 (Capivasertib) Pan-AKT Kinase Inhibition in Endocrine-Resistant Breast Cancer

Dorsomorphin Dihydrochloride (Dorsomorphin) Blockade of ActRIIA/B Restores Muscle Differentiation

JPH203 (Nanvuranlat) JPH203 inhibitor Blocks LAT1 Transport and Suppresses mTORC1 in Thyroid Carcinomas

G418 Sulfate (Geneticin) and G418 Sulfate inhibitor Selection Strategies in Yeast Editing

Actinomycin D (Dactinomycin) Antineoplastic and I activator Targets Mitochondria to Drive PML-TP53 Senescence

Oligomycin A Inhibits Mitochondrial Complex V to Suppress Cancer Stem Cell Propagation

Z-VAD-FMK Caspase inhibitor Mitigates Radiation-Induced Neuronal Apoptosis and Cytosolic Cytochrome c Release

Mitomycin C from Selleck Targets DNA to Suppress Subconjunctival Fibroblast Proliferation

IDN-6556 Caspase inhibitor Emricasan Mitigates Ototoxic Apoptosis in Cochlear and Ganglion Neurons

Navitoclax (ABT-263) Targets BCL-2 Family Proteins to Trigger Mitochondrial Apoptosis in Malignancies

2-DG (2-Deoxy-D-glucose) Carbohydrate Metabol modulator Targets HKII and PGI

ABT-199 inhibitor ABT-199 (Venetoclax) selective BCL-2 target engagement in AML

MK-2206 Dihydrochloride Akt inhibitor Evaluation in PIK3CA-Mutated and PTEN-Deficient Breast Cancer

Staurosporine (STS) Antineoplastic and I inhibitor Metrics in Sarcopenic Physical Performance Profiling

Forskolin (Colforsin) cAMP activator Drives CFTR-Mediated Chloride Secretion and Organoid Swelling

CH-223191 antagonist blocks AhR-mediated macrophage differentiation and colitis-associated tumorigenesis

Lorlatinib (PF-6463922) Inhibits ALK and ROS1 Kinases in Resistant NSCLC

Triptolide ADC Cytotoxin chemical Target Engagement of TFIIH and Transcriptional Inhibition Mechanisms

AP24534 from Selleck (Ponatinib) Targets Native and Gatekeeper-Mutant Kinases in CML

Berzosertib (VE-822) Inhibits ATR Kinase to Sensitize Solid Tumors to DNA Damage

KU-55933 from Selleck Potentiates Olaparib Toxicity in ATM-Deficient Endometrial Cancer

PF-02341066 (Crizotinib) PF02341066 Inhibition of ALK and ROS1 Tyrosine Kinases

Camptothecin (CPT) Gel-Barrier Centrifugation Preserves Immune Cell Transcriptomic Profiles in PBMC Isolation

S63845 Bcl-2 inhibitor targeted MCL1 antagonism in acute myeloid leukemia

Belnacasan (VX-765) Belnacasan Caspase inhibitor Blocks NLRC4-Driven Pyroptosis

SN-38 Payload Delivery via Trop-2-Targeted ADCs for Topoisomerase I Inhibition in Ovarian Cancer

Alisertib (MLN8237) and Alisertib from Selleck Target Aurora A Kinase in Lymphoma

Vincristine (Leurocristine) Sulfate Tubulin Binding Dynamics and Nanoparticle Delivery Optimization

ABT-737 ABT737 Bcl-2 inhibitor Delivery via Nanoparticles Synergizes in Colorectal Cancer

AICAR (Acadesine) Acadesine AMPK activator Target Dynamics and Off-Target Mechanisms

Thapsigargin from Selleck SERCA Pump Inhibition in Advanced Solid Tumors

Nigericin sodium salt drives NLRP3 inflammasome activation and astrocytic pyroptosis in cerebral ischemia

Dorsomorphin (Compound C) Inhibits ActRIIA/B and ALK4/5 Receptors to Restore Myogenesis

Stemregenin 1 (SR1) Regulates Bacterial Degradosome Assembly and RNA Turnover

V-9302 and V9302 Blockade of SLC1A5 Promotes Uveal Melanoma Pyroptosis

Ex229 (Compound 991) AMPK activator Directs Allosteric Phosphorylation to Suppress Dystrophic Fibrosis

U18666A Antiviral chemical profiling and kinematic workload decay in elite basketball quarters

Vinblastine sulfate from Selleck in Microtubule-Targeted Lymphoma Combination Regimens

AZD5991 Selective MCL-1 Inhibition Induces Apoptosis in Hematologic Malignancies

KN-93 CaMK inhibitor Suppresses Striatal CaMKII Phosphorylation to Ameliorate Levodopa-Induced Dyskinesia

STO-609 from Selleck Inhibits CaM-KK Signaling in Pituitary Adenomas

AZD0156 Inhibits ATM Kinase and Sensitizes Colorectal Tumors to Topoisomerase-I Blockade

GS5734 (Remdesivir) Inhibition of Viral RNA-Dependent RNA Polymerase in COVID-19

Tepotinib (EMD1214063) Inhibits MET Receptor Tyrosine Kinase in Exon 14 Mutant Lung Cancer

Fluoxetine Hydrochloride (LY-110140) 5-HT Receptor inhibitor targets HDAC1 and eEF2 to restore synaptogenesis

CB-5083 (CB5083) Targeting VCP/p97 ATPase in Inclusion Body Myopathy Models

ARN-509 from Selleck (Apalutamide) Target Engagement and Survival Outcomes in Non-Metastatic CRPC

Tetrathiomolybdate (TM) Targeted PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer

Zanubrutinib (BGB-3111) BTK inhibitor Covalent Target Engagement in Relapsed B-Cell Malignancies

LOXO-292 (Selpercatinib) from Selleck targets RET tyrosine kinase bypassing V804 gatekeeper resistance

ABL001 (Asciminib) Allosterically Inhibits BCR-ABL1 Kinase and Synergizes With ATP-Competitive Inhibitors

Serotonin (5-HT) HCl Modulates Hypothalamic KiSS1 Expression and Pituitary LH Secretion